Hypoxia Inducible Factor Alpha Inhibitor Market was valued at $720.2 million in 2025 and is projected to reach $1,426.6 million by 2035, growing at a CAGR of 7.1% during the forecast period (2026-2035).  Established HIF-2? inhibitors continue to advance clinically, with expanding evidence supporting their role in hypoxia-driven malignancies, particularly clear cell renal cell carcinoma (ccRCC). Following initial regulatory approvals of agents such as Belzutifan, ongoing studies are evaluating their use in earlier treatment lines, combination regimens, and broader tumor populations. Clinical development strategies increasingly focus on combining HIF-2? inhibition with immune checkpoint inhibitors and VEGF-targeted therapies to enhance durability of response and delay resistance. 

Guillain-barre syndrome drugs market was valued at $1.2 billion in 2025 and is projected to reach $2.2 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035).  Guillain-Barré Syndrome (GBS) is a rare, acute neuromuscular disorder characterized by an autoimmune-mediated attack on peripheral nerves, often triggered by a preceding infection in otherwise healthy individuals. The condition involves autoantibodies and activation of the classical complement pathway, leading to nerve inflammation and damage. Clinically, GBS progresses rapidly and may result in severe weakness, paralysis, and, in critical cases, respiratory failure requiring intensive care support. 

End stage renal disease drugs market was valued at $25,200.2 million in 2025 and is projected to reach $63,126.2 million by 2035, growing at a CAGR of 9.7% during the forecast period (2026-2035). End-Stage Renal Disease (ESRD) represents the final and most severe stage of chronic kidney disease, characterized by the near-complete loss of kidney function. At this critical stage, patients require renal replacement therapy in the form of lifelong dialysis or kidney transplantation to survive. According to the United States Renal Data System (USRDS) 2024 Annual Data Report, approximately 131,000 new ESRD cases were reported in 2022, bringing the total number of individuals living with ESRD in the United States to nearly 816,000. Dialysis remains the most widely adopted treatment option, with two primary modalities available: Hemodialysis (HD) and Peritoneal Dialysis (PD). Hemodialysis can be administered either in specialized dialysis centers or at home, while peritoneal dialysis is predominantly home-based. 

Starch polymer market was valued at $1.12 billion in 2025 and is projected to reach $1.91 billion by 2035, registering a CAGR of 5.6% during the forecast period from 2026 to 2035. The expanding capacity for biobased plastics production is a significant growth driver for the global starch polymer market, reflecting broader industry momentum toward renewable and biodegradable material systems. Industry associations and production data show that global biobased plastic manufacturing infrastructure is scaling rapidly to meet heightened demand from packaging, agriculture, and other industrial sectors, with starch-derived polymers playing a central role.

Silicone resuscitation mask market was valued at $1.70 billion in 2025 and is projected to reach $2.83 billion by 2035, registering a CAGR of 5.3% over the forecast period from 2026 to 2035. The tightening of infection prevention and control standards across hospitals and emergency care systems is directly influencing procurement decisions for reusable, sterilizable airway management devices. Silicone resuscitation masks are increasingly preferred due to their compatibility with high-level disinfection and autoclave sterilization processes, which aligns with updated hospital hygiene requirements. Healthcare facilities are prioritizing durable medical devices that withstand repeated reprocessing without material degradation, especially in high-patient-turnover environments. 

Shark liver oils market was valued at $156.2 million in 2025 and is expected to reach $263.6 million by 2035, registering a CAGR of 5.5% during the forecast period from 2026 to 2035. Recent developments in environmental regulation and ingredient innovation are influencing dynamics across the Global Shark Liver Oils market. In December 2025, international conservation agreements under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) were strengthened to enhance protection for endangered sharks, including deep-sea species traditionally harvested for high-value liver oil. This increased protection is expected to prompt greater sustainability scrutiny and supply chain adjustments among producers and suppliers within the shark liver oils ecosystem.

The regenerated cellulose market was valued at $21.0 billion in 2025 and is projected to reach $40.5 billion by 2035, expanding at a CAGR of 6.9% during the forecast period from 2026 to 2035. The market is increasingly driven by industry-wide sustainability commitments that are reshaping material choices across apparel, home textiles, hygiene, and technical segments. Textile producers and brand owners are shifting away from fossil-based synthetics toward biodegradable, renewable alternatives to reduce environmental impact and align with climate goals. This transition is supported by regulatory pressure, corporate disclosure requirements on emissions, and rising consumer demand for sustainable fibers,

The PVC resuscitation mask market was valued at $1.20 billion in 2025 and is expected to reach $2.16 billion by 2035, registering a CAGR of 6.2% over the forecast period from 2026 to 2035. Emergency medical response systems have become more structured and widely implemented globally, creating a clear demand driver for PVC resuscitation masks as essential life-saving equipment. Healthcare authorities and ambulance services are standardizing emergency care protocols, which routinely specify bag-valve-mask (BVM) devices with PVC masks for airway management in cardiac arrest and respiratory distress situations. Training of first responders and expansion of prehospital care units have increased the volume of PVC resuscitation masks procured by hospitals, EMS providers, and community health programs. 

Printing inks market was valued at $26.6 billion in 2025 and is projected to reach $38.5 billion by 2035, expanding at a CAGR of 3.8% over the forecast period from 2026 to 2035. Environmental sustainability is driving growth in the global printing inks market as manufacturers and brand owners shift toward low?impact ink formulations that meet stricter regulatory standards and evolving customer expectations. Regulatory frameworks in major markets are encouraging the adoption of water?based and UV?curable inks that emit significantly fewer volatile organic compounds (VOCs), while corporations pursue greener supply chains in packaging and commercial printing. Regulatory pressure and consumer sustainability preferences are influencing procurement decisions, prompting ink producers to innovate and expand eco?friendly portfolios. This focus on sustainability is reinforcing investment in R&D, enhancing product diversification, and supporting long?term market expansion across key regions, including Europe and North America.

Potassium sulphate market was estimated at $2.20 billion in 2025 and is projected to reach $3.47 billion by 2035, expanding at a CAGR of 4.8% over the forecast period from 2026 to 2035. The global potassium sulphate market is being propelled by a clear agricultural shift toward chloride-free nutrient solutions for high-value and chloride-sensitive crops. Potassium sulphate (also known as sulfate of potash) delivers essential potassium and sulfur without the negative effects of chloride ions that can harm crop roots and soil health, making it the preferred fertilizer for fruits, vegetables, tobacco, and other sensitive horticultural crops. This driver is reinforced by official fertilizer quality standards recognizing SOP’s chloride limitation and sulfur content, which supports improved crop outcomes relative to alternative potash fertilizers.